Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SORBS2 antisense RNA 1 (SORBS2-AS1) is a long non-coding RNA transcribed from the antisense strand of the SORBS2 gene locus. As an antisense transcript, its primary putative role is the regulation of SORBS2 gene expression, potentially affecting the levels and activity of the SORBS2 protein, which is an RNA-binding protein implicated in suppression of cancer metastasis and cellular adhesion. While the functional consequences of SORBS2-AS1 expression remain to be fully elucidated, antisense RNAs commonly exert post-transcriptional or epigenetic control over their sense gene counterparts, and dysregulation of antisense RNA is increasingly recognized as relevant in various disease contexts.\n\nNote: SORBS2-AS1 is distinct from SORBS2 protein, which itself is emerging as a node in cancer biology but is not synonymous with the antisense RNA. Direct disease roles, drug interventions, and functional mechanisms of SORBS2-AS1 have yet to be systematically characterized.
No drugs directly target SORBS2-AS1; any potential mechanism would involve modulation of SORBS2 gene expression via antisense interaction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SORBS2 antisense RNA 1 (SORBS2-AS1).